LAG3 and colorectal cancer: reported that LAG3 blockade could increase proliferation and effector cytokine production of intratumoral T-cells isolated from LM of colorectal cancer in response to both polyclonal and autologous tumor-specific stimulations, suggesting a new promising immunotherapeutic target for LM of colorectal cancer (37).